# Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing

> **NCT05699265** · — · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 4 (actual)

## Conditions studied

- Fabry Disease

## Interventions

- **DIAGNOSTIC_TEST:** Measures of arterial stiffness and endothelial function
- **DIAGNOSTIC_TEST:** Ambulatory blood pressure monitoring
- **DIAGNOSTIC_TEST:** Cardiopulmonary exercise testing (CPET)
- **DIAGNOSTIC_TEST:** Serum and urine biomarkers

## Key facts

- **NCT ID:** NCT05699265
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The sponsor withdrew funding since there was no progress with this study for a significant amount of time.
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05699265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05699265, "Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05699265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*